Susan Band Horwitz ’58, an internationally renowned molecular pharmacologist whose research on the drug Taxol led to its becoming one of the world’s most successful drugs in the fight against cancer, is one of three scientists to receive the 2014 John Scott Award, one of the top prizes in the world of science and medicine. Presented by […]

Mercedes K. Meyer ’88 was inducted as secretary of the American Intellectual Property Law Association (AIPLA) on Oct. 27 and will serve a one-year post. Meyer is a partner in Drinker Biddle’s Intellectual Property practice group. Meyer focuses her extensive practice on biotechnology and pharmaceutical patent prosecution. Immediately prior to her appointment as AIPLA secretary, […]

The business journal Mass High Tech has named Barbara Fox ’78, the  founder, leader and chief science officer of Avaxia Biologics, to its 2012 list of “Women to Watch.” Fox, who majored in chemistry at Bryn Mawr before going on to earn a Ph.D. at the Massachusetts Institute of Technology, holds a number of patents. “With three […]

Human Genome Sciences, Inc., a biopharmaceutical corporation that uses the human DNA sequence to develop protein and antibody drugs, announced in March that George Morrow, M.A. ’77, had been appointed to the HGS Board of Directors. Until January 2011, Morrow served as executive vice president for global commercial operations for Amgen, Inc., leading all of […]

Pacific Biosciences of California, whose chief financial officer is Susan Kelly Barnes ’76, makes superfast DNA sequencing machines with the potential to transform biological research. The company offered shares for sale to members of the public for the first time on Oct. 27, successfully raising its initial public offering (IPO) goal of $200 million. Based […]